Now showing items 1-1 of 1

    • Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome. 

      Strydom, A; Heslegrave, A; Startin, CM; Mok, KY; Hardy, J; Groet, J; Nizetic, D; Zetterberg, H; LonDownS Consortium (2018-04-10)
      BACKGROUND: Down syndrome (DS) may be considered a genetic form of Alzheimer's disease (AD) due to universal development of AD neuropathology, but diagnosis and treatment trials are hampered by a lack of reliable blood ...